Black Diamond Therapeutics (BDTX) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

BDTX is expected to report earnings to rise 25.82% to -35 cents per share on March 12

Black Diamond Therapeutics BDTX Stock Earnings Reports

Q4'24

Est.

$-0.35

Q3'24

Beat

by $0.09

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.08

Q4'23

Beat

by $0.13

The last earnings report on November 05 showed earnings per share of -28 cents, beating the estimate of -37 cents. With 208.71K shares outstanding, the current market capitalization sits at 161.27M.

View a ticker or compare two or three

Compare

BDTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BDTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Main Street

Phone

+1 617 252-0848

Employees

Web

https://www.blackdiamondtherapeutics.com